The Epidemiology of the Revision Total Hip Arthroplasty in the United States From 2016 to 2022
- PMID: 39524991
- PMCID: PMC11550771
- DOI: 10.1016/j.artd.2024.101517
The Epidemiology of the Revision Total Hip Arthroplasty in the United States From 2016 to 2022
Abstract
Background: The number of revision total hip arthroplasties (THAs) is projected to reach 572,000 cases annually by 2030 in the United States. This may be attributed to the successes of primary THAs combined with an aging population, patients desire to remain active, and expanded indications for younger patients. Given the evolving nature of revision THAs, an epidemiological analysis of (1) etiologies; (2) demographics, including age and region; and (3) lengths of stay (LOSs) may minimize the gap between appropriate understanding and effective intervention.
Methods: From 2016 to 2022, a national, all-payer database was queried. Incidences and indications were analyzed for a total of 102,476 patients who had revision THA procedures. Patients were stratified according to etiology of failure, age, US census region, primary payor class, and mean LOS.
Results: The most common etiologies for revision THA procedures were dislocation (16.7%) and infection (12.7%), followed by periprosthetic fracture (6.9%). The largest age group was 65-74 years (30.9%), followed by >75 years (28.6%), then 55-64 (26.5%). The South had the largest total procedure cohort (36.9%), followed by the Midwest (27.5%), then the Northeast (19.7%), and the West (15.9%). The mean LOS was 4.10 days (range, 1.0-20.0).
Conclusions: Dislocation and infection remain leading indications for revision THA. These findings can properly guide surgeons toward appropriate management as well as toward active steps to minimizing these outcomes.
Keywords: Dislocation; Epidemiology; Infection; Revision; Total hip arthroplasty.
© 2024 The Authors.
Figures
References
-
- Palsis J.A., Brehmer T.S., Pellegrini V.D., Drew J.M., Sachs B.L. The cost of joint replacement: comparing two approaches to evaluating costs of total hip and knee arthroplasty. JBJS. 2018;100:326–333. - PubMed
-
- Castagnini F., Sudanese A., Bordini B., Tassinari E., Stea S., Toni A. Total knee replacement in young patients: survival and causes of revision in a registry population. J Arthroplasty. 2017;32:3368–3372. - PubMed
-
- Kurtz S., Ong K., Lau E., Mowat F., Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. Jbjs. 2007;89:780–785. - PubMed
-
- Hamilton D.F., Howie C.R., Burnett R., Simpson A.H.R.W., Patton J.T. Dealing with the predicted increase in demand for revision total knee arthroplasty: challenges, risks and opportunities. Bone Joint J. 2015;97:723–728. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous